相关实验视频

Updated: Jul 26, 2025

Measurement of Basal and Forskolin-stimulated Lipolysis in Inguinal Adipose Fat Pads

Measurement of Basal and Forskolin-stimulated Lipolysis in Inguinal Adipose Fat Pads

Published on: July 21, 2017

一种新的基于石墨烯的纳米材料增加了脂解,并通过整合素相关激酶 (ILK) 减少了体重增加

Sergio de Frutos^1,2, Mercedes Griera³, Maria Del Prado Lavín-López⁴

¹Department of Systems Biology of Universidad de Alcalá (UAH), 28805 Alcalá de Henares, Madrid, Spain. sergio.frutos@uah.es.

Biomaterials science

|June 12, 2023

概括

基于石墨烯的纳米材料 (GMC) 通过增加脂解和减少脂肪生成,减少肥胖大鼠的脂肪储存. 这种新的抗肥胖策略是安全有效的局部应用,准白色脂肪组织 (WAT) 缩.

科学领域:

生物技术和纳米医学
细胞和分子生物学细胞和分子生物学
肥胖问题研究研究

背景情况:

白色脂肪组织 (WAT) 缩,由过度的甘油三储存驱动,是肥胖的一个标志.
整合素β1 (INTB1) 和整合素连接激酶 (ILK) 与肥胖和WAT缩有关.
抑制ILK是一种减少WAT缩的潜在治疗策略.

研究的目的:

研究基于石墨烯的碳纳米材料 (CNMs),特别是GMC在修改脂肪细胞特性和减少WAT缩方面的潜力.
在肥胖的老鼠模型中评估局部GMC的安全性和有效性.

主要方法:

在培养脂肪细胞中评估了GMC生物相容性和功能,使用MTT测定,甘油三含量,脂解和基因表达分析.
涉及INTB1和ILK的细胞内信号通路使用阻断抗体和siRNA进行了研究.
将GMC局部给高脂肪饮食诱导的肥胖大鼠,然后对皮下WAT (scWAT) 体重和毒性标志物的分析进行.

主要成果:

转基因糖是无毒的,并且剂量取决于脂肪细胞中降低的甘油三含量.
通过化INTB1,GMC促进了脂解,增加了激素敏感脂酶 (HSL) 的表达和活性,并增强了甘油和脂肪酸的运输.
GMC降低了脂肪生成标志物,在肥胖大鼠的SCWAT中过度表达ILK,导致减轻体重增加,没有系统毒性.

结论:

GMC是一种安全有效的局部治疗方法,用于降低缩的scWAT体重,在抗肥胖策略中显示出前景.
通过INTB1激活和ILK过度表达,GMC通过增加脂解和减少脂肪生成来发挥其抗肥胖作用.
这项研究强调了GMC在调节脂肪代谢标志物的潜力,以获得治疗肥胖的治疗益处.

更多相关视频

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Measuring the Rate of Lipolysis in Ex Vivo Murine Adipose Tissue and Primary Preadipocytes Differentiated In Vitro

Published on: March 17, 2023

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

An Adipocyte Cell Culture Model to Study the Impact of Protein and Micro-RNA Modulation on Adipocyte Function

Published on: May 4, 2021

相关概念视频

Glucagon-like Receptor Agonists

Glucagon-like Receptor Agonists

Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...

Intracellular Signaling Affects Focal Adhesions

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...